ContractXponent Data License Agreement • August 18th, 2003 • Dendrite International Inc • Services-prepackaged software
Amendment To Restated Xponent Data License Agreement Dated April 26, 2001 Between IMS Health Incorporated And Interactive Marketing Division of Synavant, Inc. This amendment (“Amendment”), effective as of June 16, 2003 (the “Effective Date”), is entered into by and among IMS Health Incorporated (“IMS”), Synavant, Inc. (“Licensee”), and Dendrite International, Inc. (“Dendrite”) and supplements, modifies and is hereby made part of the Restated Xponent Data License Agreement dated April 26, 2001, with an effective date of September 1, 2000, as amended by an Addendum and Amendment to such agreement dated September 1, 2002, (the “Agreement”) between IMS and Licensee. 1. Background Licensee has agreed to be acquired by Dendrite and/or certain of its affiliates (such acquisition hereinafter referred to as the “Transaction”). In connection with the Transaction, the parties, by a letter agreement dated May 8, 2003 (the “Extension Agreement”) agreed to enter into an extension of the Agreement o
AMENDMENTDistribution Agreement • August 18th, 2003 • Dendrite International Inc • Services-prepackaged software • New York
ThisAMENDMENT TO DISTRIBUTION AGREEMENT (this “Amendment”), dated as of June 16, 2003, between IMS Health Incorporated (“IMS”) and Synavant Inc. (“Synavant”).
ContractCross License Agreement • August 18th, 2003 • Dendrite International Inc • Services-prepackaged software
EXECUTION COPY CROSS LICENSE AGREEMENT AGREEMENT, dated as of this 31st day of August, 2000, (“Effective Date”) by and between IMS Health Incorporated (hereinafter “IMS”), a Delaware corporation with an address at 200 Nyala Farms, Westport, Connecticut 06880, for and on behalf of the Affiliates listed in the Exhibits hereto, and Synavant Inc. (hereinafter “ST”), a Delaware corporation, with an address at 3445 Peachtree Road, N.E., Suite 1400, Atlanta, Georgia 30326 for and on behalf of the Affiliates listed in the Exhibits hereto. RECITALS WHEREAS, IMS, among other things, provides information services to the pharmaceutical industry; WHEREAS, ST , among other things, collects and makes commercially available certain demographic and profiling information on health care professionals (e.g., doctors, nurses, pharmacists) and health care providers (e.g., hospitals, pharmacies, clinics) in various countries around the world (“Pharbase Services”); and WHEREAS, IMS desires to provide certain
